- Home
- JKHY vs BAX Comparison
JKHY vs BAX Comparison
Compare JKHY & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JKHY
- BAX
- Stock Information
- Founded
- JKHY 1976
- BAX 1931
- Country
- JKHY United States
- BAX United States
- Employees
- JKHY N/A
- BAX N/A
- Industry
- JKHY Retail: Computer Software & Peripheral Equipment
- BAX Medical/Dental Instruments
- Sector
- JKHY Technology
- BAX Health Care
- Exchange
- JKHY Nasdaq
- BAX Nasdaq
- Market Cap
- JKHY 11.9B
- BAX 9.2B
- IPO Year
- JKHY N/A
- BAX N/A
- Fundamental
- Price
- JKHY $164.01
- BAX $18.12
- Analyst Decision
- JKHY Hold
- BAX Hold
- Analyst Count
- JKHY 9
- BAX 10
- Target Price
- JKHY $176.22
- BAX $27.00
- AVG Volume (30 Days)
- JKHY 971.5K
- BAX 9.3M
- Earning Date
- JKHY 11-04-2025
- BAX 10-30-2025
- Dividend Yield
- JKHY 1.42%
- BAX 0.22%
- EPS Growth
- JKHY 20.28
- BAX N/A
- EPS
- JKHY 6.58
- BAX N/A
- Revenue
- JKHY $2,419,044,000.00
- BAX $11,023,000,000.00
- Revenue This Year
- JKHY $6.98
- BAX $5.72
- Revenue Next Year
- JKHY $6.45
- BAX $2.52
- P/E Ratio
- JKHY $24.87
- BAX N/A
- Revenue Growth
- JKHY 7.75
- BAX 3.90
- 52 Week Low
- JKHY $144.12
- BAX $17.40
- 52 Week High
- JKHY $196.00
- BAX $37.74
- Technical
- Relative Strength Index (RSI)
- JKHY 62.03
- BAX 32.35
- Support Level
- JKHY $159.78
- BAX $17.57
- Resistance Level
- JKHY $168.43
- BAX $18.92
- Average True Range (ATR)
- JKHY 3.33
- BAX 0.60
- MACD
- JKHY 0.77
- BAX 0.01
- Stochastic Oscillator
- JKHY 80.45
- BAX 30.56
About JKHY Jack Henry & Associates Inc.
Jack Henry is a leading provider of core processing and complementary services, such as electronic funds transfer, payment processing, and loan processing for US banks and credit unions, with a focus on small and midsize banks. Jack Henry serves almost 1,000 banks and over 700 credit unions.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.